The incomplete distribution of HIV therapy, coupled with uneven HIV transmission rates throughout a population, seem to predict a failure of commodity health care to reduce HIV incidence. Paradoxically, heterogeneity in HIV transmission risk combined with the appropriately targeted antiretroviral therapeutic strategy may offer a substantial public health benefit if HIV surveillance and treatment can be coordinated.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The epidemiological impact of antiretroviral use predicted by mathematical models: a review
Emerging Themes in Epidemiology Open Access 10 September 2005
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Anderson, R.M., Gupta, S. & May, R.M. The potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1. Nature 350, 356 (1991).
Blower, S., Gershengorn, H.B. & Grant, R.M. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 287, 650–654 (2000).
Palella, F.J. et al. The HIV outpatient investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338, 853–860 (1998).
Kravcik, S. et al. Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sex practices. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19, 24–29 (1998).
Angel, J.B. et al. in 7th Conf. Retrovir. Opportunistic Infect. abstract LB2 (Foundation for Retrovirology and Human Health, 2000).
Quinn, T.C. et al. in 7th Conf. Retrovir. Opportunistic Infect. abstract 193 (Foundation for Retrovirology and Human Health, 2000).
Kashuba, A.D.M. et al. Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 43, 1817–1826 (1999).
Cameron, D.W. Can we reduce HIV transmission by providing healthcare and HIV therapy to commercial sex workers? J. Int. Ass. Physicians AIDS Care 4, 24–26 (1998).
Garnett, G.P. & Anderson, R.M. Antiviral therapy and the transmission dynamics of HIV-1. J. Antimicrob. Chemother. 37, Suppl. B, 135–150 (1996).
Garnett, G.P., Ferguson, N.M., Ghani, A.C. & Anderson, R.M. Assessing the epidemiologic impact of combination therapy. 7th Eur. Conf. Clin.l Aspects Treat. HIV Inf. (The European AIDS Clinical Society, 1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garnett, G., Bartley, L., Cameron, D. et al. Both a ‘magic bullet’ and good aim are required to link public health interests and health care needs in HIV infection. Nat Med 6, 261–262 (2000). https://doi.org/10.1038/73104
Issue Date:
DOI: https://doi.org/10.1038/73104
This article is cited by
-
The epidemiological impact of antiretroviral use predicted by mathematical models: a review
Emerging Themes in Epidemiology (2005)
-
Diagnostic et test du virus de l’hépatite C
Canadian Journal of Public Health (2000)